Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18776428 | 0.89 | AHCY (0.34) | ADORA3MEN1KMT2ADOT1L | |
| SCHEMBL18776430 | 0.88 | ADORA3 (0.32) | ADORA3MEN1KMT2ADOT1L | |
| SCHEMBL18776431 | 0.86 | ADORA2A (0.34) | ADORA3 | |
| SCHEMBL18776462 | 0.84 | ADORA3 (0.36) | ADORA3MEN1KMT2ADOT1L | |
| SCHEMBL18776432 | 0.82 | ADORA3 (0.40) | ADORA3 | |
| SCHEMBL18776422 | 0.80 | — | — | |
| SCHEMBL26355063 | 0.73 | DOT1L (0.35) | DOT1L | |
| SCHEMBL18776436 | 0.72 | ADORA3 (0.40) | ADORA3 | |
| SCHEMBL18776426 | 0.72 | ADORA3 (0.43) | ADORA3 | |
| SCHEMBL12022990 | 0.72 | MARS1 (0.34) | ADORA3MEN1KMT2ADOT1L |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114341-A1 | POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS | BRADSHAW CURT W (US) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114341-A1 | POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS | HNRNPC, RNASE1, NSUN3 | ADORA3 3873/4885MEN1 2230/4885KMT2A 3810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.